Cargando…
Nelfinavir Inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly
BACKGROUND: Antiviral therapies that target herpesviruses are clinically important. Nelfinavir is a protease inhibitor that targets the human immunodeficiency virus (HIV) infections aspartyl protease. Previous studies demonstrated that this drug could also inhibit Kaposi’s sarcoma-associated herpesv...
Autores principales: | Li, Maggie, Smith, Barbara, Jaeyeun, Lee, Petr, Jennifer, Wiseman, Robyn, Anders, Nicole, Rudek, Michelle, Ambinder, Richard, Desai, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659537/ https://www.ncbi.nlm.nih.gov/pubmed/37986957 http://dx.doi.org/10.21203/rs.3.rs-3552962/v1 |
Ejemplares similares
-
Unveiling kaposi sarcoma viral antigens
por: Lee, Jaeyeun, et al.
Publicado: (2017) -
Kaposi sarcoma herpesvirus pathogenesis
por: Mariggiò, Giuseppe, et al.
Publicado: (2017) -
Kaposi’s Sarcoma Herpesvirus Genome Persistence
por: Juillard, Franceline, et al.
Publicado: (2016) -
Kaposi's sarcoma-associated herpesvirus at 27
por: Gaglia, Marta Maria
Publicado: (2021) -
Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors.
por: Kang, G. H., et al.
Publicado: (1998)